Share chart GeoVax Labs, Inc.
Extended chart
Simple chart
About GeoVax Labs, Inc.
GeoVax Labs, Inc., биотехнологическая компания клинической стадии, разрабатывает человеческие вакцины и иммунотерапию против инфекционных заболеваний и рака с использованием модифицированной вакцинной платформы на основе вирусоподобных частиц осповакцины анкара. Разрабатывает различные профилактические вакцины против (COVID-19), вируса иммунодефицита человека (ВИЧ); вирус Зика; малярия; и вирусы геморрагической лихорадки, такие как Эбола, Судан, Марбург и Ласса, а также терапевтические вакцины против ВИЧ, хронических инфекций гепатита В и солидных опухолей. more details| IPO date | 1999-04-09 |
|---|---|
| ISIN | US3736785078 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | https://www.geovax.com |
| Цена ао | 1.37 |
| Change price per day: | -0% (1.37) |
|---|---|
| Change price per week: | +1.48% (1.35) |
| Change price per month: | -6.8% (1.47) |
| Change price per 3 month: | -41.7% (2.35) |
| Change price per half year: | -44.08% (2.45) |
| Change price per year: | -31.5% (2) |
| Change price per 3 year: | +30.48% (1.05) |
| Change price per 5 year: | +482.98% (0.235) |
| Change price per year to date: | -41.7% (2.35) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Armistice Capital, LLC | 108435 | 4.99 |
| Vanguard Group Inc | 48563 | 2.24 |
| Blackrock Inc. | 27563 | 1.27 |
| Geode Capital Management, LLC | 11526 | 0.53 |
| State Street Corporation | 6529 | 0.3 |
| Northern Trust Corporation | 2281 | 0.11 |
| Renaissance Technologies, LLC | 1913 | 0.09 |
| Welch & Forbes, LLC | 1133 | 0.05 |
| Tower Research Capital LLC (TRC) | 684 | 0.03 |
| Wells Fargo & Company | 281 | 0.01 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. David Alan Dodd | Chairman, President & CEO | 384.2k | 1950 (75 years) |
| Dr. Mark J. Newman Ph.D. | Chief Scientific Officer | 291.5k | 1955 (70 years) |
| Dr. Kelly T. McKee Jr., M.D., M.P.H. | Chief Medical Officer | 361.03k | 1950 (75 years) |
| Dr. Harriet Latham Robinson Ph.D. | Founder, Chief Scientific Officer Emeritus & Member of Scientific Advisory Board | N/A | 1938 (87 years) |
| Dr. John W. Sharkey Ph.D. | Vice President of Business Development | N/A | 1956 (69 years) |
| Mr. Jeffrey Welch | Head of Process Development & Manufacturing Operations | N/A | |
| Mr. John Niles | Head of Commercial Operations | N/A | |
| Mr. Thomas O'Brien | Vice President of Quality Systems & Compliance |
Address: United States, Smyrna. GA, 1900 Lake Park Drive - open in Google maps, open in Yandex maps
Website: https://www.geovax.com
Website: https://www.geovax.com
